Health Evaluation of Returning Travelers
CDC Travel Health Notice: Global Measles Outbreak
Measles outbreaks are now occurring in multiple countries around the world, meaning that the number of measles cases is higher than normal for those countries. Unvaccinated travelers infected with measles overseas have brought the disease back to the United States, causing outbreaks among unvaccinated people in their local communities. Before you travel internationally, regardless of where you are going, make sure you are protected fully against measles. If you are not sure, see your healthcare provider at least one month before your scheduled departure.
See the CDC Travel Health Notice for more information on the global measles outbreak and what you can do. See the TDH reportable diseases website for a description of the illness, guidelines for healthcare providers and laboratories for reporting and testing, and additional guidance.
Tennessee Department of Health Healthcare Associated Infections Program Asks Facilities to Screen Patients for Candida auris and Carbapenemase Producing Organisms (CPOs)
Patients who have had healthcare abroad are considered high-risk for colonization with multidrug-resistant organisms such as Candida auris and Carbapenemase Producing Organisms (CPOs). To help prevent the spread of these organisms in Tennessee, the Tennessee Department of Health (TDH) Healthcare Associated Infections and Antimicrobial Resistance (HAI/AR) Program recommends that all patients who have had healthcare abroad (except for Canada) be screened for C. auris and CPOs.
Countries of particular concern for C. auris include India, Kenya, Kuwait, Pakistan, South Africa, the United Arab Emirates, and Venezuela. U.S. cases of C. auris have been linked to healthcare stays in these countries. Please note that many other countries have documented transmission or multiple cases of C. auris. In addition, countries may have undetected or unreported cases of C. auris.
Certain areas of the U.S. are also of particular concern for C. auris. These areas are New York City, New Jersey, Chicago, Orange County California, and Broward and Miami Counties in Florida. The TDH HAI/AR Program recommends screening patients who have had overnight healthcare in these areas of the U.S.
For more information on where C. auris has been found, both around the globe and in the U.S., please visit https://www.cdc.gov/fungal/candida-auris/tracking-c-auris.html.
For more information on which patients should be screened for C. auris and CPOs, please see our Travel Screening Guidance.